ATE378015T1 - System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes - Google Patents

System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes

Info

Publication number
ATE378015T1
ATE378015T1 AT00945223T AT00945223T ATE378015T1 AT E378015 T1 ATE378015 T1 AT E378015T1 AT 00945223 T AT00945223 T AT 00945223T AT 00945223 T AT00945223 T AT 00945223T AT E378015 T1 ATE378015 T1 AT E378015T1
Authority
AT
Austria
Prior art keywords
anticoagulant
surrogate markers
patient
treating
prevent
Prior art date
Application number
AT00945223T
Other languages
English (en)
Inventor
John Mcmichael
Original Assignee
Dimensional Dosing Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimensional Dosing Systems Inc filed Critical Dimensional Dosing Systems Inc
Application granted granted Critical
Publication of ATE378015T1 publication Critical patent/ATE378015T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00945223T 1999-07-06 2000-07-06 System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes ATE378015T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/348,592 US6267116B1 (en) 1999-07-06 1999-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug

Publications (1)

Publication Number Publication Date
ATE378015T1 true ATE378015T1 (de) 2007-11-15

Family

ID=23368686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945223T ATE378015T1 (de) 1999-07-06 2000-07-06 System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes

Country Status (15)

Country Link
US (2) US6267116B1 (de)
EP (1) EP1191894B1 (de)
JP (1) JP2003503165A (de)
KR (1) KR20020036790A (de)
CN (1) CN1359276A (de)
AT (1) ATE378015T1 (de)
AU (1) AU5919800A (de)
BR (1) BR0012241A (de)
CA (1) CA2362429C (de)
DE (1) DE60037116T2 (de)
IL (1) IL147201A0 (de)
MX (1) MXPA01013306A (de)
NO (2) NO20020043D0 (de)
TR (1) TR200103831T2 (de)
WO (1) WO2001002050A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
EP1311202A4 (de) * 2000-08-24 2007-04-18 Dimensional Dosing Systems Inc Verfahren und vorrichtung zur revision der antikoagulantdosis
US6578582B2 (en) * 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
US6883521B2 (en) * 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2003026727A1 (en) * 2001-09-28 2003-04-03 Lifevent Limited sETHOD AND APPARATUS FOR DELIVERY OF MEDICATION
US20050154537A1 (en) * 2003-12-12 2005-07-14 Kutzko John D. Methods, program products, and systems for single and multi-agent dosing and other related methods
PL1862233T3 (pl) * 2006-06-01 2011-07-29 Wila Bv Narzędzie z automatycznym zatrzaskiem zabezpieczającym
EP1862255B1 (de) * 2006-06-01 2011-03-16 Wila B.V. Auswechselbares Werkzeug/Manipulator Kombination
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US8112290B2 (en) * 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
ES2927105T3 (es) * 2008-10-20 2022-11-02 Epitome Pharmaceuticals Ltd Métodos y sistemas para mejorar la intervención farmacéutica en el control de la coagulación
WO2011163506A2 (en) 2010-06-23 2011-12-29 University Of Louisville Research Foundation, Inc. Methods and kits for predicting a response to an erythropoietic agent
US9852267B2 (en) 2011-09-30 2017-12-26 University Of Louisville Research Foundation, Inc. System and method for personalized dosing of pharmacologic agents
US10083400B2 (en) 2012-10-05 2018-09-25 Diane R. MOULD System and method for providing patient-specific dosing as a function of mathematical models updated to account for an observed patient response
AU2016245862A1 (en) 2015-04-09 2018-02-22 Diane R. Mould Systems and methods for patient-specific dosing
US20190043501A1 (en) * 2017-08-02 2019-02-07 Elements of Genius, Inc. Patient-centered assistive system for multi-therapy adherence intervention and care management
US12046341B2 (en) * 2021-10-05 2024-07-23 Bradford Rabin Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR20240033436A (ko) 2022-09-05 2024-03-12 박세경 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템
US12295943B2 (en) 2023-09-22 2025-05-13 Closed Loop Medicine Ltd Apixaban dosing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug

Also Published As

Publication number Publication date
MXPA01013306A (es) 2002-07-02
NO20020056D0 (no) 2002-01-07
CN1359276A (zh) 2002-07-17
US6267116B1 (en) 2001-07-31
DE60037116T2 (de) 2008-09-11
IL147201A0 (en) 2002-08-14
JP2003503165A (ja) 2003-01-28
TR200103831T2 (tr) 2002-10-21
WO2001002050A2 (en) 2001-01-11
EP1191894A4 (de) 2004-10-20
NO20020043D0 (no) 2002-01-04
AU5919800A (en) 2001-01-22
CA2362429A1 (en) 2001-01-11
BR0012241A (pt) 2002-03-26
CA2362429C (en) 2005-07-05
KR20020036790A (ko) 2002-05-16
US6942614B1 (en) 2005-09-13
EP1191894A2 (de) 2002-04-03
WO2001002050A3 (en) 2002-01-10
NO20020056L (no) 2002-01-07
EP1191894B1 (de) 2007-11-14
DE60037116D1 (de) 2007-12-27

Similar Documents

Publication Publication Date Title
ATE378015T1 (de) System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes
ATE515229T1 (de) Vorrichtung zur erfassung eines markers zur überwachung der befolgung einer arzneimitteltherapie
NO996229L (no) Heparanase spesifikke molekylære prober og deres anvendelse i forskning og medisin
WO2003011215A3 (en) Method and system to determine revised dosage
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
WO2002082972A3 (en) Method and apparatus to optimize drug therapy
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
EP1162457A3 (de) Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung
Slichter et al. Dysbaric osteonecrosis: a consequence of intravascular bubble formation, endothelial damage, and platelet thrombosis
PT87997A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
Lee The infection control of dental impressions
Shupack et al. Human skin reactions to ethylene oxide
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ATE441437T1 (de) Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren
Greenberg et al. Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants
Fisher Management of dermatitis due to surgical gloves
RU2115119C1 (ru) Способ оценки эффективности лечебного или разрушающего воздействия на здоровье человека
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
RO‘Brien An in vivo trial of an anti-adhesive drug
Sohma et al. Effect of isoflurane and halothane on regional cardiac stiffness
Palatucci Paradoxical halide levels in bromide intoxication
Ganapati et al. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay
Chalker et al. Hepatitis B: A hazard for dermatologists
Woerlee Perioperative Management of Platelet Disorders

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties